Septerna Stock Alert: Company Announces Discontinuation of Phase 1 Clinical Trial, Shares Plummet - Kehoe Law Firm, P.C. Investigating Securities Claims on Behalf of SEPN Investors
1. Kehoe Law Firm investigates potential securities claims for Septerna investors. 2. Concerns over Septerna's compliance could impact investor confidence and SEPN stock.